A detailed history of Virtus ETF Advisers LLC transactions in Hille Vax, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 6,230 shares of HLVX stock, worth $11,400. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,230
Previous 6,117 1.85%
Holding current value
$11,400
Previous $88,000 88.64%
% of portfolio
0.0%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.58 - $14.42 $178 - $1,629
113 Added 1.85%
6,230 $10,000
Q2 2024

Aug 14, 2024

BUY
$11.86 - $15.93 $72,547 - $97,443
6,117 New
6,117 $88,000

Others Institutions Holding HLVX

About HilleVax, Inc.


  • Ticker HLVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,427,200
  • Market Cap $61.2M
  • Description
  • HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.
More about HLVX
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.